Skip to content
Open access

Immune Profiling after treatment with an Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Treatment-Refractory Progressive Multiple Sclerosis

Sep 2026 · medRxiv · 0 citations
Medicine
Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.